Treatment of steroid‐resistant checkpoint inhibitor pneumonitis with pirfenidone: A case report

With the increased use of immune checkpoint inhibitors (ICIs) in lung cancer, which are of great benefit to patients, more and more immune‐related adverse events (irAEs) are being reported. Checkpoint inhibitor pneumonitis (CIP) is one of the most challenging adverse events, which pose a huge challe...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Kang, Xu, Yan, Xu, Wenshuai, Zhang, Ying, Xu, Yongjian, Tian, Xinlun, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327698/
https://www.ncbi.nlm.nih.gov/pubmed/34145962
http://dx.doi.org/10.1111/1759-7714.13921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327698/
https://www.ncbi.nlm.nih.gov/pubmed/34145962
http://dx.doi.org/10.1111/1759-7714.13921

Ejemplares similares